AML-MOacute myelogenous leukemia with minimal differentiation
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
Also if a patient with an acute leukemia showing heterogeneous blasts that has no morphological or cytochemical markers of myeloid differentiation with unavailability of further differentiating procedures then it may be treated as ALL-L2, as statistically speaking it would be much more possible than AML-MO (7).